OV17RHomo sapiens (Human)Cancer cell line
Also known as: OV-17R
🤖 AI SummaryBased on 2 publications
Quick Overview
OV17R is a human cell line used in cancer research.
Detailed Summary
OV17R is a human cell line derived from an unknown tissue and is associated with an unknown disease. The cell line is categorized under an unknown cell type. Research on OV17R focuses on understanding its properties and potential applications in cancer studies. Due to the lack of detailed information, further investigation is required to determine its specific characteristics and roles in cancer research.
Research Applications
Cancer research
Key Characteristics
Human cell lineUnknown tissue originUnknown disease association
Generated on 6/19/2025
Basic Information
| Database ID | CVCL_2672 |
|---|---|
| Species | Homo sapiens (Human) |
| Tissue Source | Ascites[UBERON:UBERON_0007795] |
Donor Information
| Age | 50 |
|---|---|
| Age Category | Adult |
| Sex | Female |
Disease Information
| Disease | Adenocarcinoma of ovary |
|---|---|
| Lineage | Ovary/Fallopian Tube |
| Subtype | Serous Ovarian Cancer |
| OncoTree Code | SOC |
DepMap Information
| Source Type | Sigma-Aldrich |
|---|---|
| Source ID | ACH-001373_source |
Known Sequence Variations
| Type | Gene/Protein | Description | Zygosity | Note | Source |
|---|---|---|---|---|---|
| MutationSimple | TP53 | p.Val216Met (c.646G>A) | Unspecified | - | Unknown |
| MutationSimple | APC | p.Glu1317Gln (c.3949G>C) | Unspecified | - | PubMed=25230021 |
Haplotype Information (STR Profile)
Short Tandem Repeat (STR) profile for cell line authentication.
Amelogenin
X
CSF1PO
11,14
D13S317
11,13
D16S539
9,13
D18S51
13,18
D19S433
14,16
D21S11
30
D2S1338
24,25
D3S1358
14,17
D5S818
11
D7S820
8,10
D8S1179
13,14
FGA
21,22
Penta D
10,13
Penta E
14
TH01
9
TPOX
8,10
vWA
14,18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines
Loading gene expression data...
Publications
Pan-cancer proteomic map of 949 human cell lines.";
Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.
Cancer Cell 40:835-849.e8(2022).
An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.
Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.
Cancer Res. 79:1263-1273(2019).
Interrogation of functional cell-surface markers identifies CD151 dependency in high-grade serous ovarian cancer.
Drapkin R.I., Ailles L., Mes-Masson A.-M., Rottapel R.
Cell Rep. 18:2343-2358(2017).
A landscape of pharmacogenomic interactions in cancer.";
Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
Cell 166:740-754(2016).
Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes.
Helleman J.
PLoS ONE 9:E103988-E103988(2014).